The current prices are delayed, login to your account for live prices
LOGIN
Create Alert
Watchlist

Sun Pharmaceutical Industries

0.00
0.00 (0.00%) 1D
NSE
1D
1W
1M
3M
6M
1Y
3Y
5Y
All
Overview
News
Events
F&O

Performance

Open
0.00
Prev. Close
0.00
Volume
NA
Total traded value
NA
Upper Circuit
NA
Lower Circuit
NA

Analyst Estimates

89%
Buy
89%
Hold
6%
Sell
6%
Aggregated by Refinitiv from 35 Analysts

Fundamentals

Market Cap₹4,20,136Cr
ROE15.99%
P/E Ratio(TTM)36.75
EPS(TTM)47.65
P/B Ratio6.08
Dividend Yield0.77%
Industry P/E33.98
Book Value288.06
Debt to Equity0.04
Face Value1
Understand Fundamentals

Financials

Revenue
Profit
Net Worth
*All values are in Rs. Cr
12,63112,58913,18513,64514,141Dec '23Mar '24Jun '24Sep '24Dec '24
Quarterly
Yearly

About Sun Pharmaceutical

Sun Pharmaceutical Industries Limited is an India-based specialty generic pharmaceutical company. The Company is engaged in the business of manufacturing, developing and marketing a wide range of branded and generic formulation and active pharmaceutical ingredients (APIs). It produces a comprehensive, diverse and complementary portfolio of generic and specialty medicines targeting a wide spectrum of chronic and acute treatments. The Company's vertically integrated network enables it to produce a wide range of pharmaceuticals, including oncology, hormones, peptides, and steroidal drugs. The Company also has a product portfolio in RoW markets, including injectables, hospital products and retail products. It offers a variety of dosage forms, including orals, creams, ointments, injectables, sprays, and liquids. Its marketed specialty portfolio includes Ilumya/ Ilumetri, Winlevi, Levulan Kerastick + BLU-U, Absorica LD, Odomzo, Cequa, Bromsite, Xelpros, Yonsa, Sezaby and Sprinkle portfolio. ;
Parent OrganisationSun Pharmaceutical Industries Limited
Managing DirectorNA
NSE SymbolSUNPHARMA

Shareholding Pattern

Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Promoters
54.48%
Foreign Institutions
18.05%
Mutual Funds
12.24%
Retail And Others
8.92%
Other Domestic Institutions
6.31%

Similar Stocks

COMPANY
52 WEEK
MARKET PRICE
P/E Ratio
Cipla
NA
(0.00%)
24.53
Mankind Pharma
NA
(0.00%)
52.20
Dr Reddy's Laboratories
NA
(0.00%)
18.08
Lupin
NA
(0.00%)
30.83
Groww
Want to invest in this stock?
Open a free Demat account in minutes to start investing in stocks.
ⓒ 2016-2025 Groww. All rights reserved, Built with in India
MOST POPULAR ON GROWWVERSION - 5.9.5
STOCK MARKET INDICES:  S&P BSE SENSEX |  S&P BSE 100 |  NIFTY 100 |  NIFTY 50 |  NIFTY MIDCAP 100 |  NIFTY BANK |  NIFTY NEXT 50
MUTUAL FUNDS COMPANIES:  GROWWMF |  SBI |  AXIS |  HDFC |  UTI |  NIPPON INDIA |  ICICI PRUDENTIAL |  TATA |  KOTAK |  DSP |  CANARA ROBECO |  SUNDARAM |  MIRAE ASSET |  IDFC |  FRANKLIN TEMPLETON |  PPFAS |  MOTILAL OSWAL |  INVESCO |  EDELWEISS |  ADITYA BIRLA SUN LIFE |  LIC |  HSBC |  NAVI |  QUANTUM |  UNION |  ITI |  MAHINDRA MANULIFE |  360 ONE |  BOI |  TAURUS |  JM FINANCIAL |  PGIM |  SHRIRAM |  BARODA BNP PARIBAS |  QUANT |  WHITEOAK CAPITAL |  TRUST |  SAMCO |  NJ

ABOUT GROWW